ProPhase Labs to Present at the 2024 ThinkEquity Conference
October 22 2024 - 8:00AM
ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a
next generation biotech, genomics, and diagnostics company, today
announced that it will be participating in The ThinkEquity
Conference on October 30, 2024, at the Mandarin Oriental Hotel in
New York. Past ThinkEquity conferences have featured over 70
company presentations, 700+ attendees, and 500+ one-on-one
meetings, providing a valuable platform for companies and investors
to connect.".
Ted Karkus, CEO and Chairman of the Board of
Directors, will be presenting at 1PM ET on October 30th. One-on-one
investor meetings will be held throughout the day. Interested
investors can register to attend and schedule one-on-one meetings
here.
The presentation will also be live-streamed at the following
link:
https://wsw.com/webcast/tep25/prph/1692576
About ProPhase Labs
ProPhase Labs Inc. (Nasdaq: PRPH) (“ProPhase”)
is a next-generation biotech, genomics and diagnostics company. Our
goal is to create a healthier world with bold action and the power
of insight. We’re revolutionizing healthcare with industry-leading
Whole Genome Sequencing solutions, while developing potential game
changer diagnostics and therapeutics in the fight against cancer.
This includes a potentially life-saving cancer test focused on
early detection of esophageal cancer and potential breakthrough
cancer therapeutics with novel mechanisms of action. Our
world-class CLIA labs and cutting-edge diagnostic technology
provide wellness solutions for healthcare providers and consumers.
We develop, manufacture, and commercialize health and wellness
solutions to enable people to live their best lives. We are
committed to executional excellence, smart diversification, and a
synergistic, omni-channel approach. ProPhase Labs’ valuable
subsidiaries, their synergies, and significant growth underscore
our multi-billion-dollar potential.
Media Relations and Institutional Investor
Contact:
ProPhase Labs,
Inc.267-880-1111investorrelations@prophaselabs.com
Retail Investor Relations Contact:
Renmark Financial CommunicationsJohn
Boidman514-939-3989Jboidman@renmarkfinancial.com
Source: ProPhase Labs, Inc.
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Nov 2024 to Dec 2024
ProPhase Labs (NASDAQ:PRPH)
Historical Stock Chart
From Dec 2023 to Dec 2024